# TORNTPHARM share price, delivery % and history — Torrent Pharmaceuticals Limited

> Delivery percentage for Torrent Pharmaceuticals Limited (TORNTPHARM) against its own history, with 7,810 sessions of split-adjusted NSE data from 1995 — plus moving averages, RSI and the 52-week range.

Canonical: https://patternsradar.com/s/TORNTPHARM

NSE · equity · [Healthcare](https://patternsradar.com/stocks/sector/healthcare.md) · [Pharmaceuticals & Biotechnology](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md)

## Latest session

- Close: 4,800 INR (-1.92% on the day), 2026-09-30
- Delivery: 56.45% of volume taken to demat (20-day average 61.59%)
- Volume: 3.98L shares, turnover ₹191.0Cr
- Relative volume: 1.12× of its own 20-day average

## Technicals

- RSI(14): 42.82
- ATR(14): 111.45
- SMA 50: 4,941.16, SMA 200: 4,431.35
- 52-week range: 3,480.6 – 5,250 (-8.57% from the high)

## Performance

- 1 week -3.71%, 1 month -5.25%, 3 months 2.97%
- 6 months 12.53%, 1 year 31.45%

## Delivery percentage

- Latest: 56.45% (2026-09-30)
- 20-day average: 61.59%
- 1-year average: 57.22%
- Percentile against its own history: 67th
- Range: 8.44% – 86.6% across 1,728 sessions with a reading

Over the last 20 sessions TORNTPHARM settled 61.6% of its traded quantity, which is unusually high for an NSE equity. Its one-year average is 57.2%, so recent sessions are running 4.4 points higher than usual. The latest session ranks higher than 67% of the 1,728 sessions on record for it.

[What delivery percentage measures](https://patternsradar.com/learn/delivery-percentage.md). [Scan the whole market on delivery](https://patternsradar.com/scans/delivery.md).

## Fundamentals

- Market cap: 1,82,576.6 crore
- P/E (TTM): 84.68 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 56.68 INR, split-adjusted to match the price series
- Revenue growth: 54.85% YoY, 17.25% QoQ
- Profit growth: 3.28% YoY, 55.49% QoQ

Compound annual growth, trailing-twelve-month against the same measure N years earlier:

| Window | Revenue | Profit |
| --- | --- | --- |
| 2y | 19.58% | 11.47% |
| 3y | 16.81% | 19.61% |
| 5y | 14.23% | 11.32% |
| 6y | 11.98% | 11.37% |
| 7y | 10.49% | 23.61% |

## Quarterly results

Last 8 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2024-09-30 | 2,889 | 2,212 | 661 | 453 | 13.37 | 15.68% |
| 2024-12-31 | 2,809 | 2,151 | 691 | 503 | 14.88 | 17.91% |
| 2025-03-31 | 2,959 | 2,252 | 665 | 498 | 14.71 | 16.83% |
| 2025-06-30 | 3,178 | 2,403 | 738 | 548 | 16.19 | 17.24% |
| 2025-09-30 | 3,302 | 2,471 | 791 | 591 | 17.45 | 17.9% |
| 2025-12-31 | 3,303 | 2,466 | 814 | 635 | 18.77 | 19.22% |
| 2026-03-31 | 4,197 | 3,585 | 529 | 364 | 11.51 | 8.67% |
| 2026-06-30 | 4,921 | 4,155 | 733 | 566 | 14.87 | 11.5% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-07-20:

- Promoter: 60.78%
- Public: 39.22%
- FII: 17.97%, DII: 12.87%
- Promoter shares pledged: 0%

## Recent filings

- 2026-07-30: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_180669_30072026173512_iXBRL_WEB.html
- 2026-07-20: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1697244_20072026060641_WEB.xml
- 2026-07-20: shareholding for 2026-07-20 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1697348_20072026063703_WEB.xml
- 2026-07-20: shareholding for 2026-07-20 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1697348_20072026063703_WEB.xml
- 2026-07-20: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1697244_20072026060641_WEB.xml
- 2026-05-29: dividend
- 2026-05-23: results for 2026-03-31 standalone — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_160505_23052026120251_iXBRL_WEB.html
- 2026-05-22: results for 2026-03-31 consolidated — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_160371_22052026203819_iXBRL_WEB.html

Dated by the day the company broadcast the filing. 156 events are indexed for this instrument.

## About the instrument

- Listed: 1995-01-03 — latest session 2026-09-30 (7,810 sessions)
- ISIN: INE685A01028
- Series: EQ
- Liquidity rank: #171 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

## More in Pharmaceuticals & Biotechnology

- [DIVISLAB](https://patternsradar.com/s/DIVISLAB.md) — Divi's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [LAURUSLABS](https://patternsradar.com/s/LAURUSLABS.md) — Laurus Labs Limited (Pharmaceuticals & Biotechnology)
- [WOCKPHARMA](https://patternsradar.com/s/WOCKPHARMA.md) — Wockhardt Limited (Pharmaceuticals & Biotechnology)
- [SUNPHARMA](https://patternsradar.com/s/SUNPHARMA.md) — Sun Pharmaceutical Industries Limited (Pharmaceuticals & Biotechnology)
- [MOREPENLAB](https://patternsradar.com/s/MOREPENLAB.md) — Morepen Laboratories Limited (Pharmaceuticals & Biotechnology)
- [DRREDDY](https://patternsradar.com/s/DRREDDY.md) — Dr. Reddy's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [SYMBIOTEC](https://patternsradar.com/s/SYMBIOTEC.md) — SYMBIOTEC (Pharmaceuticals & Biotechnology)
- [GLAND](https://patternsradar.com/s/GLAND.md) — Gland Pharma Limited (Pharmaceuticals & Biotechnology)
- [ZYDUSLIFE](https://patternsradar.com/s/ZYDUSLIFE.md) — Zydus Lifesciences Limited (Pharmaceuticals & Biotechnology)
- [LUPIN](https://patternsradar.com/s/LUPIN.md) — Lupin Limited (Pharmaceuticals & Biotechnology)
- [AHCL](https://patternsradar.com/s/AHCL.md) — Anlon Healthcare Limited (Pharmaceuticals & Biotechnology)
- [CIPLA](https://patternsradar.com/s/CIPLA.md) — Cipla Limited (Pharmaceuticals & Biotechnology)

[All Pharmaceuticals & Biotechnology stocks on the NSE](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md) · [All Healthcare stocks on the NSE](https://patternsradar.com/stocks/sector/healthcare.md)

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/TORNTPHARM.

---

Price and delivery data from the [eod2](https://github.com/BennyThadikaran/eod2) dataset: National Stock Exchange of India end-of-day files, split- and bonus-adjusted, updated after each close. Not affiliated with or endorsed by NSE. PatternsRadar is a research tool. Nothing here is investment advice or a recommendation to buy or sell anything.